NucleoSkin for Under-Eye Rejuvenation: Dosage, Injection Technique, and Patient Selection

NW Aesthetics
Jul 12
6 min read

The periorbital area is, without question, the hardest zone on the face to treat well. The skin under the eye is roughly a third the thickness of skin on the cheek, there's almost no subcutaneous fat to buffer an injection, and every dermatologist who's spent time in this area knows that what works beautifully on the mid-face can look lumpy, bluish, or simply wrong around the eye. This is exactly why polynucleotide skin boosters — and specifically PDRN-based formulations like NucleoSkin — have become the go-to option for practitioners in India who've grown cautious about hyaluronic acid filler in this zone.

If you've been fielding more questions from patients about tear trough hollowing, crepey under-eye skin, or that persistent dusky discolouration that doesn't respond to sleep or skincare, this is worth reading closely. We'll walk through where NucleoSkin fits for the periorbital area, how dosing and technique differ from other treatment zones, and what a realistic session and results timeline looks like.

Why PDRN Behaves Differently Under the Eye

NucleoSkin combines PDRN (2500KD) at 20mg/ml with hyaluronic acid at 10mg/ml and glutathione at 2mg/ml — a formulation developed and manufactured in Italy under pharmaceutical-grade standards. The PDRN component is derived from highly purified salmon DNA fragments, and its mechanism is what makes it suited to thin, fragile skin in a way that volumising fillers often aren't.

Once injected, PDRN binds to A2A adenosine receptors on fibroblasts. This isn't a filling or volumising action — it's a signalling one. It switches on fibroblast activity, upregulates collagen and elastin synthesis, and drives angiogenesis, which improves microcirculation in an area that's notoriously vascular and prone to pooling. For a patient with dark circles rooted in vascular stasis rather than pigmentation, this matters clinically — you're not masking discolouration, you're addressing one of its physiological drivers. The glutathione component adds an antioxidant, mild-brightening effect that complements this, while the HA at a modest 10mg/ml provides light hydration without the volumising heft that risks a puffy or overfilled look under the eye.

In short: this is a regenerative approach to periorbital rejuvenation, not a filling one. That distinction should shape how you set expectations with patients from the first consultation.

Patient Selection for Under-Eye PDRN Therapy

Not every under-eye complaint is a PDRN candidate, and knowing who to screen out is as important as technique itself.

Good candidates typically present with:

Fine crepey texture and early loss of skin elasticity in the lower lid
Dull, bluish, or brownish discolouration without significant true volume loss
Mild static and dynamic fine lines that don't yet warrant neuromodulator or filler
Mild Hollowness / Volume Loss of the Under Eye
Patients wanting a "prejuvenation" approach before committing to filler
Post-filler patients whose tear trough looks technically corrected but texturally still tired

Poor candidates, or those needing a combination approach instead of PDRN alone:

True structural volume loss with a deep, hollow tear trough — HA filler will still be the primary tool here, with NucleoSkin as an adjunct for skin quality
Active periorbital dermatitis, eczema, or unhealed skin barrier issues
Known hypersensitivity to fish or fish-derived products — always screen for this explicitly, given the salmon-derived origin of PDRN
Pregnancy, breastfeeding, active infection at the injection site, or bleeding disorders

A screening question worth adding to your intake form: "Do you have any known allergy to fish or seafood?" It takes five seconds and prevents a genuinely avoidable adverse event.

NucleoSkin Under-Eye Protocol: Dosage and Injection Technique

This is general clinical guidance reflecting how PDRN skin boosters are commonly used in the periorbital zone. It is not a substitute for the official NucleoSkin product training and IFU (Instructions for Use) that NW Aesthetics provides to onboarded clinics — always defer to that documentation and your own clinical judgement for individual patients.

Total volume per session: For the periorbital area alone, most practitioners work within a conservative 0.5–1ml per side, delivered in very small aliquots rather than a single bolus. Given each NucleoSkin vial contains 3ml, a single vial comfortably covers bilateral under-eye treatment with volume left over for adjacent zones like the crow's feet or upper cheek if the protocol calls for it.

Depth and technique: The periorbital area is not the place for deep bolus injection. Two techniques dominate:

Micro-bolus (papule) technique — tiny 0.02–0.05ml deposits placed intradermally, roughly 0.5- 1 cm apart, in the immediate sub-dermal or supra-periosteal plane depending on how much tissue laxity you're navigating. This is the more common approach directly under the lash line and along the tear trough.
Linear threading (retrograde) — a fine needle or cannula is threaded along the orbital rim and product is deposited in a slow retrograde motion. Many practitioners favour a 30mm 27–30G cannula here specifically because it reduces bruising risk in a zone where the skin is thin and vascularity is high.

Whichever technique you use, intradermal placement is the priority. Go too deep and you lose the localised regenerative effect where the skin actually needs it; go too bolus-heavy and you risk visible or palpable papules that can take days to settle in thin skin.

Injection mapping: Most protocols use a grid pattern along the orbital rim, staying at least 5–8mm below the lash line and respecting the orbital septum to avoid deeper structures. Avoid injecting directly over visible vasculature — walk the needle slightly off-vessel and aspirate where technique allows.

Session frequency: A course of 3–4 sessions spaced 3-4 weeks apart is the standard induction protocol for the under-eye area, followed by a maintenance session every 4–6 months. This mirrors the broader NucleoSkin protocol used across face, neck, and hand indications, though the periorbital area often benefits from slightly tighter spacing early on given how thin and reactive the skin is.

Combining NucleoSkin with Other Modalities

In practice, few dermatologists use PDRN under the eye in complete isolation — it tends to sit within a broader periorbital protocol:

With HA tear trough filler: NucleoSkin is frequently used as a pre-treatment or interspersed adjunct to improve skin quality and reduce the risk of a "filled but tired-looking" result. Many practitioners run one or two PDRN sessions before introducing filler, then maintain with PDRN between filler touch-ups.
With energy-based devices: Where a clinic also runs a device like MShape for facial toning, PDRN skin boosting pairs naturally as the injectable arm of a broader periorbital rejuvenation package — one addresses skin quality, the other addresses underlying muscle tone and contour.
With topical antioxidants: Given the glutathione component already in NucleoSkin, a simple vitamin C or peptide-based home care routine tends to extend and complement results between sessions rather than duplicate the mechanism.

What Results and Timeline Look Like

Patients should be counselled honestly here — PDRN is regenerative, not instant. Most practitioners report visible improvement in skin texture and hydration within 1–2 weeks of the first session, with more meaningful change in fine lines, tone, and that overall "tired eye" look building progressively across the 3–4 session induction course. Full collagen remodelling effects — the part that genuinely changes skin quality rather than just plumping it temporarily — typically continue to build for 4–8 weeks after the last session in the course.

This is worth setting up front in consultation: a patient expecting filler-level immediate correction after one under-eye PDRN session will be disappointed. A patient told honestly that this is a cumulative, skin-quality-first treatment tends to be a far happier, more compliant, and more repeat-booking patient.

Frequently Asked Questions

Is NucleoSkin safe for the under-eye area specifically? Yes, when used with an appropriately superficial technique and after standard contraindication screening (particularly fish allergy, given the salmon-derived PDRN). The periorbital area requires more conservative volumes and shallower placement than other facial zones, which is a technique consideration rather than a safety limitation of the product itself.

How is PDRN different from hyaluronic acid filler under the eyes? HA filler works by adding volume to correct hollowing. PDRN works by stimulating the patient's own fibroblast activity to improve skin quality, hydration, and microcirculation. They address different problems and are often used together rather than as substitutes for one another.

How many NucleoSkin sessions are needed for visible under-eye improvement? Most protocols use 3–4 sessions spaced two to three weeks apart for the initial course, with a maintenance session roughly every four to six months thereafter.

Can NucleoSkin help with dark circles? It can help with dark circles that are vascular or textural in origin — where discolouration is linked to thin skin and poor microcirculation. It's less effective for dark circles caused primarily by pigmentation or deep structural shadowing from volume loss, which need a pigment-targeted or volumising approach respectively.

Where can clinics in India source NucleoSkin PDRN? NucleoSkin is distributed pan-India by NW Aesthetics as the official partner for Promoitalia's Italian-manufactured PDRN range. Clinics interested in stocking NucleoSkin or arranging practitioner training on periorbital technique can reach out through nwaesthetics.in.

This article is intended for licensed dermatologists and aesthetic physicians and reflects general clinical practice patterns for PDRN-based skin boosters. It does not replace official product training, the NucleoSkin IFU, or individualised clinical judgement. For practitioner onboarding, dosage charts, and periorbital technique training, contact the NW Aesthetics clinical team.